Therapy Tolerability
Therapy Tolerability is a clinical evaluation metric that assesses the degree to which a patient can adhere to and withstand the adverse effects of a prescribed hepatitis D treatment regimen without dose reduction, interruption, or discontinuation.
1.3K
Publications
70K
Citations
9.6K
Authors
3K
Institutions
Publications per year
2017–2026
417
Parents
1.3K
Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · Journal of Clinical Oncology · 2019 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +17
Joachim Stangier, Karin Rathgen, Hildegard Stähle et al. · British Journal of Clinical Pharmacology · 2007 · 884 citations · Full text
1–5 of 1.3K
9.6K
8
h-index
7
h-index
6
h-index
6
h-index
5
h-index
1–5 of 9.6K
3K
Harvard University
Cambridge, United States
22 h-index
79 publications
11.8K citations
Inserm
Paris, France
22 h-index
60 publications
5K citations
Heidelberg University
Heidelberg, Germany
18 h-index
101 publications
37.6K citations
Dana-Farber Cancer Institute
Boston, United States
18 h-index
115 publications
6.7K citations
Novartis (Switzerland)
Basel, Switzerland
18 h-index
83 publications
5.6K citations

Cornell University
Ithaca, United States
17 h-index
47 publications
4.9K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
17 h-index
46 publications
2.8K citations
University College London
London, United Kingdom
16 h-index
49 publications
2K citations
1–8 of 3K
89 publications · 10.6K citations
36
h-index
Repository · 125 publications · 3.8K citations
31
h-index
CMRO · 18 publications · 694 citations
15
h-index
14 publications · 943 citations
13
h-index
12 publications · 1.2K citations
12
h-index
1–5